Abstract
This paper presents a new concept combining flexible organic light-emitting diode (OLED) display technology with fluorescent biorecognition microarray technology to fabricate point-of-care immunobiosensors. Our approach is designed to leverage commercial OLED display technology to reduce pre-functionalized biosensor substrate costs to pennies per cm2 combined with leveraging the display industries ability to manufacture an immense number of low-cost consumer electronic products annually. For this work, we demonstrate that our new approach using high brightness flexible OLED display technology combined with a charge integrating readout circuit and optical filters can offer point-of-care diagnostic sensitivity at or below 10 pg/mL, which approaches the lower limit of detection (LLOD) of typical clinical laboratory instrumentation.
Original language | English (US) |
---|---|
Article number | 7270272 |
Pages (from-to) | 273-280 |
Number of pages | 8 |
Journal | Journal of Display Technology |
Volume | 12 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2016 |
Keywords
- Biomarkers
- OLED
- flexible display
- flexible electronics
- fluorescent biorecognition
- microarray
- organic light emitting diodes (OLEDs)
- point-of-care
- thin-film transistors (TFTs)
ASJC Scopus subject areas
- Electronic, Optical and Magnetic Materials
- Condensed Matter Physics
- Electrical and Electronic Engineering